Synlogic

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Synlogic and other ETFs, options, and stocks.

About SYBX

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs.

CEO

Mary Beth Dooley

CEOMary Beth Dooley

Employees

Employees1

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2007

Founded2007

Employees

Employees1

SYBX Key Statistics

Market cap

13.45M

Market cap13.45M

Price-Earnings ratio

9.81

Price-Earnings ratio9.81

Dividend yield

—

Dividend yield—

Average volume

7.99K

Average volume7.99K

High today

$1.15

High today$1.15

Low today

$1.15

Low today$1.15

Open price

$1.15

Open price$1.15

Volume

325.00

Volume325.00

52 Week high

$1.88

52 Week high$1.88

52 Week low

$0.898

52 Week low$0.898

People also own

Based on the portfolios of people who own SYBX. This list is generated using Robinhood data, and it’s not a recommendation.

Synlogic

Why Robinhood?

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs. Show more

SYBX Key Statistics

People also own

Synlogic, Inc. is a biopharmaceutical company which engages in the discovery and development of synthetic biotic medicines. It focuses on phenylketonuria, enteric hyperoxaluria, immuno-oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs.